@article{528c93565d96479e8a98cf3e6635a8bd,
title = "Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain",
abstract = "Failure of remyelination underlies the progressive nature of demyelinating diseases such as multiple sclerosis. Macrophages and microglia are crucially involved in the formation and repair of demyelinated lesions. Here we show that myelin uptake temporarily skewed these phagocytes toward a disease-resolving phenotype, while sustained intracellular accumulation of myelin induced a lesion-promoting phenotype. This phenotypic shift was controlled by stearoyl-CoA desaturase-1 (SCD1), an enzyme responsible for the desaturation of saturated fatty acids. Monounsaturated fatty acids generated by SCD1 reduced the surface abundance of the cholesterol efflux transporter ABCA1, which in turn promoted lipid accumulation and induced an inflammatory phagocyte phenotype. Pharmacological inhibition or phagocyte-specific deficiency of Scd1 accelerated remyelination ex vivo and in vivo. These findings identify SCD1 as a novel therapeutic target to promote remyelination.",
keywords = "CHOLESTEROL EFFLUX, MYELIN PHAGOCYTOSIS, FATTY-ACIDS, ELECTROSPRAY-IONIZATION, STIMULATED MACROPHAGES, DEFICIENCY PROTECTS, GENE-EXPRESSION, FOAM CELLS, MICE, REMYELINATION",
author = "Bogie, {Jeroen F. J.} and Elien Grajchen and Elien Wouters and Corrales, {Aida Garcia} and Tess Dierckx and Sam Vanherle and Jo Mailleux and Pascal Gervois and Esther Wolfs and Jonas Dehairs and {Van Broeckhoven}, Jana and Bowman, {Andrew P.} and Ivo Lambrichts and Jan-Ake Gustafsson and Remaley, {Alan T.} and Monique Mulder and Johannes Swinnen and Mansour Haidar and Ellis, {Shane R.} and Ntambi, {James M.} and Noam Zelcer and Hendriks, {Jerome J. A.}",
note = "Funding Information: The work has been supported by the Flemish Fund for Scientific Research (FWO Vlaanderen; 12J9116N, 12JG119N, 12U7718N, and G099618N), the Belgian Charcot Foundation (FCS-2016-EG7, R-8676, and R-6832), the Interreg V-A EMR program (EURLIPIDS, EMR23), and the special research fund UHasselt (BOF). J.-{\AA}. Gustafsson is supported by the Robert A. Welch Foundation (E-0004), the Swedish Cancer Fund, and the Center for Innovative Medicine. N. Zelcer is an Established Investigator of the Dutch Heart Foundation (2013T111) and is supported by a European Research Council Consolidator grant (617376) and by a Netherlands Organization for Scientific Research Vici grant (NWO; 016.176.643). J.M. Ntambi is supported by a National Institutes of Health grant (R01 DK062388). Publisher Copyright: {\textcopyright} 2020 Bogie et al.",
year = "2020",
month = may,
doi = "10.1084/jem.20191660",
language = "English",
volume = "217",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "5",
}